# Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation

> **NCT01385124** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **DRUG:** Oral Cannabidiol

## Key facts

- **NCT ID:** NCT01385124
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01385124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01385124, "Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01385124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*